On Monday, Capricor Therapeutics Inc (NASDAQ: CAPR) opened lower -3.91% from the last session, before settling in for the closing price of $15.61. Price fluctuations for CAPR have ranged from $3.52 to $23.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 434.62%. Company’s average yearly earnings per share was noted -43.37% at the time writing. With a float of $39.96 million, this company’s outstanding shares have now reached $40.33 million.
Let’s determine the extent of company efficiency that accounts for 102 employees. In terms of profitability, gross margin is 95.71%, operating margin of -154.68%, and the pretax margin is -146.86%.
Capricor Therapeutics Inc (CAPR) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Capricor Therapeutics Inc is 12.13%, while institutional ownership is 18.58%. The most recent insider transaction that took place on Sep 20 ’24, was worth 14,999,998. In this transaction 10% Owner of this company bought 2,798,507 shares at a rate of $5.36, taking the stock ownership to the 7,090,351 shares.
Capricor Therapeutics Inc (CAPR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -43.37% per share during the next fiscal year.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
Check out the current performance indicators for Capricor Therapeutics Inc (CAPR). In the past quarter, the stock posted a quick ratio of 4.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 29.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.06, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Looking closely at Capricor Therapeutics Inc (NASDAQ: CAPR), its last 5-days average volume was 1.08 million, which is a drop from its year-to-date volume of 1.33 million. As of the previous 9 days, the stock’s Stochastic %D was 83.36%. Additionally, its Average True Range was 1.25.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 57.16%, which indicates a significant decrease from 70.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.51% in the past 14 days, which was lower than the 141.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.92, while its 200-day Moving Average is $9.37. However, in the short run, Capricor Therapeutics Inc’s stock first resistance to watch stands at $15.54. Second resistance stands at $16.09. The third major resistance level sits at $16.37. If the price goes on to break the first support level at $14.71, it is likely to go to the next support level at $14.43. Should the price break the second support level, the third support level stands at $13.88.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
There are currently 45,470K shares outstanding in the company with a market cap of 682.05 million. Presently, the company’s annual sales total 25,180 K according to its annual income of -22,290 K. Last quarter, the company’s sales amounted to 2,260 K and its income totaled -12,560 K.
